Second primary breast cancers are more frequent in carriers of BRCA1/BRCA2 mutations and this higher frequency drives early genetic testing to inform surgical decision-making, even though recent studies have questioned the role of BRCA1/BRCA2 mutations in breast cancer survival [16]. The gene discussed is BRCA2; the disease is breast carcinoma.